STATEMENT OF
COMMISSIONER JONATHAN S. ADELSTEIN
RE: Investigation of the Spectrum Requirements for Advanced Medical Technologies, ET 
Docket No. 06-135; Amendment of Parts 2 and 95 of the Commission’s Rules to 
Establish the Medical Device Radiocommunication Service at 401-402 and 405-406 
MHz, RM-11271; DexCom, Inc., Request for Waiver of the Frequency Monitoring 
Requirements of the Medical Implant Communications Service Rules, ET Docket  No. 
05-213; Biotronik, Inc., Request for Waiver of the Frequency Monitoring 
Requirements of the Medical Implant Communications Service Rules, ET Docket No. 
03-92 
With the approval of the new Medical Device Radiocommunication Service, the Commission is 
helping to facilitate exciting new medical technologies that will improve our lives. The addition 
of two megahertz of spectrum to the Medical Implant Communications Service band will be used 
for advance diagnostic, monitoring, and therapeutic wireless radiocommunication devices that 
can help doctors better treat their patients and benefit the health and comfort of so many. I hope 
that the order will spark more research and new medical applications so that we may continue to 
make strides in health care.  For these reasons, I am pleased to support this order.  I thank the 
National Telecommunication and Information Administration and our Office of Engineering and 
Technology for their work in crafting these rules.